Merck, Schering Results Highlight Merger Need
April 21st, 2009 by 
Pit
Quarterly numbers show why Merck decided, after years of merger aversion, to buy Schering-Plough.
Posted in Uncategorized | 
Comments Off
April 21st, 2009 by Pit Dendreon Wins
April 14th, 2009 by Pit
A victory for the company's controversial prostate cancer treatment, but more debate lies ahead.
Posted in Uncategorized | Comments Off
A Boon For HIV Drugs?
April 9th, 2009 by Pit
New studies could lead more patients to seek treatment earlier. Expect Gilead Sciences to benefit.
Posted in Uncategorized | Comments Off
FDA Faces Tough Choice On New Diabetes Drug
April 3rd, 2009 by Pit
Novo Nordisk's liraglutide may help thousands of patients. It may also cause thyroid cancer.
Posted in Uncategorized | Comments Off
Walking The Vytorin Tightrope
February 23rd, 2009 by Pit
Researchers worried about a cancer risk for the blockbuster heart drug for a year.
Posted in Uncategorized | Comments Off